SAT 028-042 GH-Pediatrics (posters)

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Pediatric Endocrinology-Clinical
Saturday, April 2, 2016: 1:15 PM-3:15 PM
Exhibit/Poster Hall (BCEC)

Nataliya Zelinska, MD, PhD1, Violeta Iotova, MD, PhD2, Julia Skorodok, MD3, Oleg Malievsky, MD, PhD4, Ron G Rosenfeld, MD5, Zvi Zadik, MD6, Ronit Koren, PhD7, Leanne Amitzi, MSc7, Oren Hershkovitz, PhD7, Gili Hart, PhD7 and Klaudziya Radziuk, MD8, (1)Children Specialized Clinical Hospital, Kiev, Ukraine
(2)UMHAT, Varna, Bulgaria
(3)St. Petersburg State Pediatric Medical Academy, St. Petersburg, Russia
(4)Bashkir State Medical University, Ufa, Russia
(5)Oregon Health and Science University, Portland, OR
(6)Kaplan Medical Center, Rehovot, Israel
(7)OPKO Biologics, Nes Ziona, Israel
(8)2nd Children City Clinic, Minsk, Belarus
Poster Board Number: SAT 028
Dennis M. Fisher, MD1, Michal Jaron Mendelson, PhD2, Leanne Amitzi, MSc2, Ronit Koren, PhD2 and Gili Hart, PhD2, (1)P Less Than, San Francisco, CA
(2)OPKO Biologics, Nes Ziona, Israel
Poster Board Number: SAT 029
David Gilfoyle, PhD1, Susanne Pihl1, Pierre Chatelain, MD2 and Michael Beckert, MD1, (1)Ascendis Pharma A/S, Hellerup, Denmark
(2)Div. Endocrinologie Pediatrique - Hopital Mère-Enfant, Univ Claude Bernard Lyon 1, Lyon, France
Poster Board Number: SAT 030
Min Ho Jung, The Catholic University of Korea, Yeouido St. Mary’s Hospital, Seoul, South Korea, Byung-Kyu Suh, Seoul St. Mary’s Hospital, Seoul, South Korea, Cheol Woo Ko, Kyungpook National University Hospital, Daegu, South Korea, Kee-Hyoung Lee, Korea University Anam Hospital, Seoul, South Korea, Dong-Kyu Jin, Samsung Medical Center, Seoul, South Korea, Han-Wook Yoo, Asan Medical Center, Seoul, South Korea, Jin Soon Hwang, Ajou University Hospital, Suwon, South Korea, Woo Yeong Chung, Inje University Busan Paik Hospital, Busan, South Korea, Heon-Seok Han, Chungbuk National University Hospital, Cheongju, South Korea, Vinay Prusty, Novo Nordisk Pharma, Seoul, South Korea and Ho-Seong Kim, Severance Hospital, Yonsei University Health System, Seoul, South Korea
Poster Board Number: SAT 031
Tadej Battelino, University Children's Hospital, Ljubljana, Slovenia, Michael Højby Rasmussen, MD, PhD, MSc, Medical & Science Insulin, Growth Hormone & Devices, Novo Nordisk A/S, Søborg, Denmark, Jean De Schepper, Univ Kinderziekenhuis Brussel, Brussels, Belgium, Nehama Zuckerman-Levin, Rambam Medical Center, Hadera, Israel, Zoran Spasico Gucev, MD, PHD, Dept of Ped Endo/Ped Clin, Univ Kiril & Metodij/Med Sch, Skopje Fyr, Macedonia, Minna B Olsen, MSc, Global Development, Novo Nordisk and Lars S Savendahl, MD, PhD, Women´s and Children´s Helath, Karolinska Institutet, Stockholm, Sweden
Poster Board Number: SAT 032
Oya Ercan1, Anders Lindberg2, Sukriye PINAR Isguven3, Merih Berberoglu4, Sule P Can5, Ece Bober6, Zeynep Sıklar4, Sukran Darcan7, Fatma Demirel8, Feyza Darendeliler1, Aysun Bideci9, Bumin Nuri Dundar10, Erdal Adal11, Zehra Aycan8, Saadet Olcay Evliyaoglu1 and Omer Faruk Tarim12, (1)Istanbul University, Istanbul, Turkey
(2)Endocrine Care, Pfizer Health AB, Sollentuna, Sweden
(3)Sakarya University, Sakarya, Turkey
(4)Ankara University, Ankara, Turkey
(5)Tepecik Training and Research Hospital, İzmir, Turkey
(6)Dokuz Eylul University, Izmir, Turkey
(7)Ege University, Izmir, Turkey
(8)Yıldırım Beyazıt University, Ankara, Turkey
(9)Gazi University, Ankara, Turkey
(10)Katip Celebi University, Izmir, Turkey
(11)Istanbul Medipol University, Istanbul, Turkey
(12)Uludag University, Bursa, Turkey
Poster Board Number: SAT 033
Peter Thygesen, Haemophilia & Growth Hormone Pharmacodynamics, Novo Nordisk A/S, Maaloev, Denmark, Gitte Konradsen, Quality & Systems Management, Novo Nordisk A/S, Maaloev, Denmark, Christine Bruun Schjødt, Biopharm API hGH, Novo Nordisk A/S, Gentofte, Denmark and Per Franklin Nielsen, Protein Characterisation 2, Novo Nordisk A/S, Maaloev, Denmark
Poster Board Number: SAT 034
Kennett Sprogoe, PhD1, Michael Beckert, MD2, Eva Dam Christoffersen3, David Gilfoyle, PhD2 and Thomas Wegge, PhD4, (1)Ascendis Pharma, Inc.
(2)Ascendis Pharma A/S, Hellerup, Denmark
(3)Ascendis Pharma A/S
(4)Ascendis Pharma GmbH
Poster Board Number: SAT 035
Christopher J Child, PhD, Lilly Diabetes, Eli Lilly and Company, Windlesham, United Kingdom, Charmian A Quigley, MBBS, FRACP, Sydney Children’s Hospital, Sydney, Australia, Alan G Zimmermann, PhD, Lilly Diabetes, Eli Lilly and Company, Indianapolis, IN, Cheri L Deal, MD, PhD, Endocrine Service, Sainte-Justine Hospital, Montreal, QC, Canada, Judith L. Ross, MD, Department of Pediatrics, Thomas Jefferson University/duPont Hospital for Children, Philadelphia, PA, Ron G Rosenfeld, MD, Oregon Health and Science University, Portland, OR, Gordon B Cutler Jr., Cutler Consulting LLC, Deltaville, VA and Werner F Blum, MD, PhD, University Children's Hospital, University of Giessen, Giessen, Germany
Poster Board Number: SAT 036
Philippe Backeljauw, MD1, Susan R Rose, MD2, Bradley Scott Miller, MD, PhD3, Peter A. Lee, MD4, Judith L. Ross, MD5, Ricardo Maamari, MD, NCMP6, Chioma Uzoigwe, MPH7 and John Germak, MD6, (1)Division of Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
(2)Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
(3)Associate Professor Pediatric Endocrinology, University of Minnesota Masonic Children's Hospital, Minneapolis, MN
(4)Pediatric Endocrinology, Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey, PA
(5)Department of Pediatrics, Thomas Jefferson University/duPont Hospital for Children, Philadelphia, PA
(6)Clinical Development, Medical and Regulatory Affairs, Novo Nordisk Inc., Plainsboro, NJ
(7)Health Economics and Outcomes Research, Novo Nordisk Inc., Plainsboro, NJ
Poster Board Number: SAT 037
Lindsey Waldman, MD, Marina E Goldis, MD, Kristen M Williams, MD, Christopher Joseph Romero, MD, Elizabeth Burtman, MD, Molly Oliver Regelmann, MD, Elizabeth Wallach, MD and Robert Rapaport, MD, Pediatric Endocrinology and Diabetes, Icahn School of Medicine at Mount Sinai, New York, NY, New York, NY
Poster Board Number: SAT 038
Dennis M. Fisher, MD1, Michal Jaron Mendelson, PhD2, Leanne Amitzi, MSc2, Ronit Koren, PhD2 and Gili Hart, PhD2, (1)P Less Than, San Francisco, CA
(2)OPKO Biologics, Nes Ziona, Israel
Poster Board Number: SAT 039
Hae Sang Lee, M.D. Ph.D., Pediatrics, Ajou University School of Medicine, Suwon, South Korea, Jungsub Lim, M.D., Ph.D., Department of Pediatrics, Korea Cancer Center Hospital, Seoul, South Korea and Jin Soon Hwang, M.D., Ph.D., Department of Pediatrics, Ajou University, School of Medicine, Suwon City, South Korea
Poster Board Number: SAT 040
Michel Polak, Pediatric Endocrinology, Diabetology and Gynaecology, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France, Jo Blair, Department of Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, Primoz Kotnik, Department of Pediatric Endocrinology, University Children's Hospital, University Medical Centre, Ljubljana, Slovenia, Effie Pournara, Novo Nordisk Health Care AG, Zurich, Switzerland, Birgitte Tønnes Pedersen, Novo Nordisk A/S, Søborg, Denmark and Tilman R Rohrer, Department of Pediatrics and Adolescent Medicine, Saarland University Medical Center, Homburg, Germany
Poster Board Number: SAT 041
Maria Dolores Rodríguez-Arnao1, Amparo Rodríguez Sánchez1, Rosario Peláez Muñoz2, Ignacio Díez López3, Joaquín Ramírez Fernándes4, Jose Antonio Bermúdez de la Vega5, Virginia Ballano6, Ruari Duffy7 and Ekaterina B Koledova8, (1)Paediatric Endocrinology Unit, Pediatric Service, Hospital General Universitario Gregorio Marañón, Madrid, Spain
(2)TFS Develop, Barcelona, Spain
(3)Pediatric Endocrinology Unit, Pediatric Service,, Hospital Universitario Araba, Araba/Alava, Spain
(4)Pediatric Endocrinology Unit, Pediatric Service, Hospital Universitario Príncipe de Asturias, Madrid, Spain
(5)Pediatric Endocrinology, Centro Nuevas Tecnologias, Sevilla, Spain
(6)Regional Clinical Operations, Merck S.L., Madrid, Spain
(7)Merck Healthcare, Global Business Franchise Medical Devices, ARES Trading SA, Coinsins, Coinsins, Switzerland
(8)Global Medical, Safety & CMO, Merck, Darmstadt, Germany
Poster Board Number: SAT 042

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire